- Home
- MESA vs BRNS Comparison
MESA vs BRNS Comparison
Compare MESA & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MESA
- BRNS
- Stock Information
- Founded
- MESA 1982
- BRNS 2016
- Country
- MESA United States
- BRNS United Kingdom
- Employees
- MESA N/A
- BRNS N/A
- Industry
- MESA Air Freight/Delivery Services
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- MESA Consumer Discretionary
- BRNS Health Care
- Exchange
- MESA Nasdaq
- BRNS Nasdaq
- Market Cap
- MESA 42.2M
- BRNS 36.0M
- IPO Year
- MESA 2018
- BRNS 2021
- Fundamental
- Price
- MESA $0.93
- BRNS $1.00
- Analyst Decision
- MESA
- BRNS Strong Buy
- Analyst Count
- MESA 0
- BRNS 1
- Target Price
- MESA N/A
- BRNS $3.00
- AVG Volume (30 Days)
- MESA 124.7K
- BRNS 11.5K
- Earning Date
- MESA 08-15-2025
- BRNS 08-07-2025
- Dividend Yield
- MESA N/A
- BRNS N/A
- EPS Growth
- MESA N/A
- BRNS N/A
- EPS
- MESA N/A
- BRNS N/A
- Revenue
- MESA $424,030,000.00
- BRNS $14,969,000.00
- Revenue This Year
- MESA $39.81
- BRNS N/A
- Revenue Next Year
- MESA N/A
- BRNS N/A
- P/E Ratio
- MESA N/A
- BRNS N/A
- Revenue Growth
- MESA N/A
- BRNS 4381.74
- 52 Week Low
- MESA $0.68
- BRNS $0.64
- 52 Week High
- MESA $1.89
- BRNS $1.58
- Technical
- Relative Strength Index (RSI)
- MESA 41.50
- BRNS 53.30
- Support Level
- MESA $0.91
- BRNS $0.90
- Resistance Level
- MESA $0.97
- BRNS $0.94
- Average True Range (ATR)
- MESA 0.04
- BRNS 0.05
- MACD
- MESA -0.00
- BRNS 0.00
- Stochastic Oscillator
- MESA 27.27
- BRNS 96.80
About MESA Mesa Air Group Inc.
Mesa Air Group Inc is a regional air carrier providing scheduled passenger service. It provides services to the District of Columbia, Canada, Cuba, and Mexico, and cargo services out of Cincinnati/Northern Kentucky International Airport. Flights are operated as American Eagle, United Express, or DHL Express flights to the terms of capacity purchase agreements with American and United and a flight services agreement with DHL. The business has a presence in domestic hubs and cities, including Dallas, Houston, Phoenix, and Washington-Dulles, and other regions.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.